Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 105Observational 4

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Arthritis, Rheumatoid 3Infections 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × tocilizumab × Clear all
NCT04291755 2024-04-05

Development and Analysis of a Stool Bank for Cancer Patients

Persephone Biosciences

Recruiting
100 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT02778789 2019-09-26

Re-Bone

University of Erlangen-Nürnberg Medical School

Completed
66 enrolled

Arthritis, Rheumatoid

NCT01362062 2017-08-02

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Hoffmann-La Roche

Completed
110 enrolled 19 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡